Home › Idiopathic Thrombocytopenic Purpura › Arizona
Idiopathic Thrombocytopenic Purpura clinical trials in Arizona
3 studies for Idiopathic Thrombocytopenic Purpura are looking for participants at sites in Arizona.
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
- Ironwood Cancer and Research Centers, Chandler
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT07421167Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
- Palo Verde Cancer Specialists Palo Verde Hematology Oncology, Ltd Glendale, Glendale
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT07104565A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
- Mayo Clinic Hospital Scottsdale, Phoenix
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 1, 2026 · NCT06544499From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.